US Stock MarketDetailed Quotes

ASMB Assembly Biosciences

Watchlist
  • 16.700
  • +0.130+0.78%
Close Nov 13 16:00 ET
  • 16.700
  • 0.0000.00%
Post 16:00 ET
106.15MMarket Cap-2423P/E (TTM)

Assembly Biosciences Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
8.53M
5.79M
7.16M
7.16M
0
0
0
0
0
0
Operating revenue
--8.53M
--5.79M
--7.16M
--7.16M
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
18.57%20.74M
-15.57%16.51M
-23.70%71.81M
-14.20%19.71M
-35.70%15.05M
-28.83%17.49M
-15.56%19.56M
-3.28%94.11M
8.13%22.98M
-6.88%23.4M
Selling and administrative expenses
-9.83%4.48M
-7.52%4.64M
-5.08%22.91M
42.17%8.71M
-19.86%4.22M
-26.78%4.97M
-15.86%5.01M
-16.14%24.13M
-5.83%6.13M
-20.80%5.27M
-General and administrative expense
-9.83%4.48M
-7.52%4.64M
-5.08%22.91M
42.17%8.71M
-19.86%4.22M
-26.78%4.97M
-15.86%5.01M
-16.14%24.13M
-5.83%6.13M
-20.80%5.27M
Research and development costs
29.83%16.26M
-18.34%11.88M
-30.12%48.9M
-34.69%11.01M
-40.30%10.82M
-29.61%12.52M
-15.45%14.55M
2.12%69.98M
14.28%16.85M
-1.86%18.13M
Operating profit
30.22%-12.2M
45.15%-10.73M
31.31%-64.65M
45.38%-12.55M
35.70%-15.05M
28.83%-17.49M
15.56%-19.56M
-3.37%-94.11M
-8.13%-22.98M
-23.98%-23.4M
Net non-operating interest income expense
146.11%1.46M
171.26%1.65M
237.67%3.45M
178.22%1.62M
145.31%628K
428.57%592K
757.75%609K
238.41%1.02M
477.23%583K
255.56%256K
Non-operating interest income
146.11%1.46M
171.26%1.65M
237.67%3.45M
178.22%1.62M
145.31%628K
428.57%592K
757.75%609K
238.41%1.02M
477.23%583K
255.56%256K
Other net income (expense)
Income before tax
36.40%-10.75M
52.10%-9.08M
34.26%-61.2M
51.20%-10.93M
37.70%-14.42M
30.93%-16.9M
17.93%-18.95M
29.68%-93.09M
64.33%-22.4M
-23.09%-23.15M
Income tax
406K
33K
0
0
Net income
34.00%-11.15M
52.10%-9.08M
34.23%-61.23M
51.05%-10.96M
37.70%-14.42M
30.93%-16.9M
17.93%-18.95M
28.31%-93.09M
62.83%-22.4M
-23.09%-23.15M
Net income continuous Operations
34.00%-11.15M
52.10%-9.08M
34.23%-61.23M
51.05%-10.96M
37.70%-14.42M
30.93%-16.9M
17.93%-18.95M
28.31%-93.09M
62.83%-22.4M
-23.09%-23.15M
Minority interest income
Net income attributable to the parent company
34.00%-11.15M
52.10%-9.08M
34.23%-61.23M
51.05%-10.96M
37.70%-14.42M
30.93%-16.9M
17.93%-18.95M
28.31%-93.09M
62.83%-22.4M
-23.09%-23.15M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
34.00%-11.15M
52.10%-9.08M
34.23%-61.23M
51.05%-10.96M
37.70%-14.42M
30.93%-16.9M
17.93%-18.95M
28.31%-93.09M
62.83%-22.4M
-23.09%-23.15M
Basic earnings per share
48.97%-1.98
62.78%-1.66
42.03%-13.38
68.71%-1.74
43.75%-3.24
36.60%-3.88
22.57%-4.46
35.89%-23.08
66.18%-5.56
-17.07%-5.76
Diluted earnings per share
48.97%-1.98
62.78%-1.66
42.03%-13.38
68.71%-1.74
43.75%-3.24
36.60%-3.88
22.57%-4.46
35.89%-23.08
66.18%-5.56
-17.07%-5.76
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 8.53M5.79M7.16M7.16M000000
Operating revenue --8.53M--5.79M--7.16M--7.16M--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 18.57%20.74M-15.57%16.51M-23.70%71.81M-14.20%19.71M-35.70%15.05M-28.83%17.49M-15.56%19.56M-3.28%94.11M8.13%22.98M-6.88%23.4M
Selling and administrative expenses -9.83%4.48M-7.52%4.64M-5.08%22.91M42.17%8.71M-19.86%4.22M-26.78%4.97M-15.86%5.01M-16.14%24.13M-5.83%6.13M-20.80%5.27M
-General and administrative expense -9.83%4.48M-7.52%4.64M-5.08%22.91M42.17%8.71M-19.86%4.22M-26.78%4.97M-15.86%5.01M-16.14%24.13M-5.83%6.13M-20.80%5.27M
Research and development costs 29.83%16.26M-18.34%11.88M-30.12%48.9M-34.69%11.01M-40.30%10.82M-29.61%12.52M-15.45%14.55M2.12%69.98M14.28%16.85M-1.86%18.13M
Operating profit 30.22%-12.2M45.15%-10.73M31.31%-64.65M45.38%-12.55M35.70%-15.05M28.83%-17.49M15.56%-19.56M-3.37%-94.11M-8.13%-22.98M-23.98%-23.4M
Net non-operating interest income expense 146.11%1.46M171.26%1.65M237.67%3.45M178.22%1.62M145.31%628K428.57%592K757.75%609K238.41%1.02M477.23%583K255.56%256K
Non-operating interest income 146.11%1.46M171.26%1.65M237.67%3.45M178.22%1.62M145.31%628K428.57%592K757.75%609K238.41%1.02M477.23%583K255.56%256K
Other net income (expense)
Income before tax 36.40%-10.75M52.10%-9.08M34.26%-61.2M51.20%-10.93M37.70%-14.42M30.93%-16.9M17.93%-18.95M29.68%-93.09M64.33%-22.4M-23.09%-23.15M
Income tax 406K33K00
Net income 34.00%-11.15M52.10%-9.08M34.23%-61.23M51.05%-10.96M37.70%-14.42M30.93%-16.9M17.93%-18.95M28.31%-93.09M62.83%-22.4M-23.09%-23.15M
Net income continuous Operations 34.00%-11.15M52.10%-9.08M34.23%-61.23M51.05%-10.96M37.70%-14.42M30.93%-16.9M17.93%-18.95M28.31%-93.09M62.83%-22.4M-23.09%-23.15M
Minority interest income
Net income attributable to the parent company 34.00%-11.15M52.10%-9.08M34.23%-61.23M51.05%-10.96M37.70%-14.42M30.93%-16.9M17.93%-18.95M28.31%-93.09M62.83%-22.4M-23.09%-23.15M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 34.00%-11.15M52.10%-9.08M34.23%-61.23M51.05%-10.96M37.70%-14.42M30.93%-16.9M17.93%-18.95M28.31%-93.09M62.83%-22.4M-23.09%-23.15M
Basic earnings per share 48.97%-1.9862.78%-1.6642.03%-13.3868.71%-1.7443.75%-3.2436.60%-3.8822.57%-4.4635.89%-23.0866.18%-5.56-17.07%-5.76
Diluted earnings per share 48.97%-1.9862.78%-1.6642.03%-13.3868.71%-1.7443.75%-3.2436.60%-3.8822.57%-4.4635.89%-23.0866.18%-5.56-17.07%-5.76
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data